These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11019972)

  • 1. Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.
    Lamfers ML; Wijnberg MJ; Grimbergen JM; Huisman LG; Aalders MC; Cohen FN; Verheijen JH; van Hinsbergh VW; Quax PH
    Thromb Haemost; 2000 Sep; 84(3):460-7. PubMed ID: 11019972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
    Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
    Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.
    Quax PH; Lamfers ML; Lardenoye JH; Grimbergen JM; de Vries MR; Slomp J; de Ruiter MC; Kockx MM; Verheijen JH; van Hinsbergh VW
    Circulation; 2001 Jan; 103(4):562-9. PubMed ID: 11157723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
    Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
    Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
    van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
    Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.
    Eefting D; Seghers L; Grimbergen JM; de Vries MR; de Boer HC; Lardenoye JW; Jukema JW; van Bockel JH; Quax PH
    Cardiovasc Res; 2010 Nov; 88(2):367-75. PubMed ID: 20562095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
    Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
    J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein.
    Wijnberg MJ; Quax PH; Nieuwenbroek NM; Verheijen JH
    Thromb Haemost; 1997 Aug; 78(2):880-6. PubMed ID: 9268189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis.
    George SJ; Angelini GD; Capogrossi MC; Baker AH
    Gene Ther; 2001 May; 8(9):668-76. PubMed ID: 11406761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.
    Apparailly F; Bouquet C; Millet V; Noel D; Jacquet C; Opolon P; Perricaudet M; Sany J; Yeh P; Jorgensen C
    Gene Ther; 2002 Feb; 9(3):192-200. PubMed ID: 11859422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
    Buttgereit P; Schakowski F; Märten A; Brand K; Renoth S; Ziske C; Schöttker B; Ebert O; Schroers R; Schmidt-Wolf IG
    Cancer Gene Ther; 2001 Jun; 8(6):430-9. PubMed ID: 11498763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T; Gu J; Zhang L; Huang X; Stephens LC; Curley SA; Fang B
    Cancer Res; 2002 Jul; 62(13):3620-5. PubMed ID: 12097263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomechanically induced gene iex-1 inhibits vascular smooth muscle cell proliferation and neointima formation.
    Schulze PC; de Keulenaer GW; Kassik KA; Takahashi T; Chen Z; Simon DI; Lee RT
    Circ Res; 2003 Dec; 93(12):1210-7. PubMed ID: 14592999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
    Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F; Lemmens G; Collen D; Lijnen HR
    Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
    Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors.
    Praus M; Wauterickx K; Collen D; Gerard RD
    Gene Ther; 1999 Feb; 6(2):227-36. PubMed ID: 10435107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.
    Gu J; Zhang L; Huang X; Lin T; Yin M; Xu K; Ji L; Roth JA; Fang B
    Oncogene; 2002 Jul; 21(31):4757-64. PubMed ID: 12101414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.